Literature DB >> 23612476

Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome.

M Rizzo1, E K Tyndall, S Frontoni, F Jacoangeli, F Sarlo, F Panebianco, A Mistorni, L Di Renzo, R Calafiore, G Luca, A De Lorenzo.   

Abstract

AIMS: Polycystic ovary syndrome (PCOS) is frequently observed in women of reproductive age, and is associated with disturbances in both reproductive and metabolic function. Insulin resistance (IR) is key to the pathophysiology of PCOS, and early detection may improve outcomes in this patient group. Rapid and straightforward laboratory tests may contribute towards early detection.
METHODS: A retrospective chart review of 185 women presenting for the first time to a gynecology clinic was carried out. Of this group, 77 met the inclusion criteria. The sample was divided according to insulin sensitivity (IS) given by the Matsuda Index, and the two groups were compared using correlation analysis. Furthermore, the sensitivity and specificity of the Matsuda, homeostasis model assessment of IR (HOMA-IR) and quantitative insulin sensitivity check index (QUICKI) indexes were compared.
RESULTS: Although bodu mass index (BMI) was higher in the insulin resistant group than the insulin sensitive group, the mean age of the IR group was actually lower. HOMA-IR and QUICKI correlated well with the Matsuda index in both groups. The HOMA-IR test showed the highest sensitivity and specificity in the detection of IR when compared to the Matsuda Index, and no added benefit was derived from using a combination of both QUICKI and HOMA- 1R.
CONCLUSIONS: In a group of 77 women diagnosed with PCOS, 49 (63.6%) had IR according to the Matsuda index. The HOMA-IR index, which is based on fasting serum insulin and glucose, correlated closely with the Matsuda index, indicating it may be a reliable substitute in the detection and subsequent early intervention required to improve outcomes in PCOS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23612476     DOI: 10.3275/8947

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  28 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

Review 2.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

3.  Should all women with PCOS be treated for insulin resistance?

Authors:  John C Marshall; Andrea Dunaif
Journal:  Fertil Steril       Date:  2012-01       Impact factor: 7.329

Review 4.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.

Authors:  A Dunaif
Journal:  Endocr Rev       Date:  1997-12       Impact factor: 19.871

5.  Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes.

Authors:  Ettore Guastella; Rosa Alba Longo; Enrico Carmina
Journal:  Fertil Steril       Date:  2010-03-19       Impact factor: 7.329

6.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

7.  Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome.

Authors:  Enrico Carmina; Rogerio A Lobo
Journal:  Fertil Steril       Date:  2004-09       Impact factor: 7.329

Review 8.  Meta-analysis: metformin treatment in persons at risk for diabetes mellitus.

Authors:  Shelley R Salpeter; Nicholas S Buckley; Justin A Kahn; Edwin E Salpeter
Journal:  Am J Med       Date:  2008-02       Impact factor: 4.965

Review 9.  Glucose intolerance in polycystic ovary syndrome--a position statement of the Androgen Excess Society.

Authors:  Kelsey E S Salley; Edmond P Wickham; Kai I Cheang; Paulina A Essah; Nicole W Karjane; John E Nestler
Journal:  J Clin Endocrinol Metab       Date:  2007-12       Impact factor: 5.958

10.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

Authors:  Bart C J M Fauser; Basil C Tarlatzis; Robert W Rebar; Richard S Legro; Adam H Balen; Roger Lobo; Enrico Carmina; Jeffrey Chang; Bulent O Yildiz; Joop S E Laven; Jacky Boivin; Felice Petraglia; C N Wijeyeratne; Robert J Norman; Andrea Dunaif; Stephen Franks; Robert A Wild; Daniel Dumesic; Kurt Barnhart
Journal:  Fertil Steril       Date:  2011-12-06       Impact factor: 7.329

View more
  2 in total

Review 1.  Markers of insulin resistance in Polycystic ovary syndrome women: An update.

Authors:  Chantal Anifa Amisi
Journal:  World J Diabetes       Date:  2022-03-15

2.  Acanthosis nigricans in the knuckles: An early, accessible, straightforward, and sensitive clinical tool to predict insulin resistance.

Authors:  Gloria González-Saldivar; René Rodríguez-Gutiérrez; Andrés Marcelo Treviño-Alvarez; Minerva Gómez-Flores; Juan Montes-Villarreal; Neri Alejandro Álvarez-Villalobos; Anasofía Elizondo-Plazas; Alejandro Salcido-Montenegro; Jorge Ocampo-Candiani; José Gerardo González-González
Journal:  Dermatoendocrinol       Date:  2018-05-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.